Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis
Chuanjie Wu(Capital Medical University), Xunming Ji(Capital Medical University), Wenbo Zhao(Capital Medical University), Qingfeng Ma(Capital Medical University), Haiqing Song(Capital Medical University), Yuping Wang(Capital Medical University), Di Wu(Capital Medical University), Nanchang Xie(First Affiliated Hospital of Zhengzhou University), Jianping Ding(Xuan Wu Hospital of the Capital Medical University), Shengming Huang(Luohe Medical College), Ming Ren(Capital Medical University), Chenghe Sun(Capital Medical University), Lijun Wang(National Center for Chronic and Noncommunicable Disease Control and Prevention), Yajun Lian(First Affiliated Hospital of Zhengzhou University)
Cited by 83
Related Papers
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Transfer of mitochondria from astrocytes to neurons after stroke
|Nature|2016|1.4k
Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2021|899
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707